Nevertheless, FMT significantly decreased serum TNF-α and MCP-1 levels, alleviating microglia activation and protein deposition, suggesting that EMR-induced systemic inflammation and the AD-like phenotype are mediated by gut microbiota. This evidence concerns the gene CCL2 and Alzheimer disease.